title: Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy.
authors.forename: Subrata
authors.initials: S
authors.lastname: Mandal
authors.forename: Subijay
authors.initials: S
authors.lastname: Sinha
authors.forename: Pradeep
authors.initials: P
authors.lastname: Venkatesh
authors.forename: Nagender
authors.initials: N
authors.lastname: Vashisht
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002648:Child; D020256:Choroidal Neovascularization / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D057826:Vitelliform Macular Dystrophy / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab